Jelli, B.; Taton, O.; D’Haene, N.; Remmelink, M.; Mekinda, Z. Complete Response to Afatinib of an EGFR Exon 18 delE709_T710insD-Mutated Stage IV Lung Adenocarcinoma. EJCRIM 2021, 8.